The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high quality Active Pharmaceutical Ingredients (APIs), Intermediates and Speciality Chemicals.

Since our inception in 1975, we have grown to become world leaders in the area of xanthine chemistry. We specialize in manufacturing APIs such as Linagliptin, Pentoxifylline, Theobromine, Doxofylline, Caffeine, Pamabrom and others. Click here for complete API list

The Group consists of entities having USFDA and WHO-GMP approvals:

• Bakul Aromatics and Chemicals Private Limited

• Bakul Pharma Private Limited

• Bakul Finechem Research Centre